Estimated reading time: 13 minutes Available in audio You can listen to this article, Medicating Appetite: The GLP-1 Dilemma, narrated in full
Seniors who are most medically motivated to start GLP-1 therapy those with severe obesity, established cardiovascular disease, or significant comorbidities are precisely the people who stand to gain the most from sustained treatment and who face the greatest health risk from abrupt discontinuation at the end of 2027
Improve Long-Term Health Beyond weight loss, GLP-1 therapy may support heart health, reduce inflammation, and help balance metabolism for lasting wellness
NAC offers a reliable way to boost the bodys internal production of antioxidants, while liposomal glutathione provides a direct, high-absorption route to the most important protective molecule in your cells
The relationship between semaglutide and yeast infections is complex, influenced by the medications impact on the gastrointestinal system, glucose metabolism, and possibly the immune system